SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000936392-06-000324
Filing Date
2006-04-07
Accepted
2006-04-07 17:22:44
Documents
4
Period of Report
2006-05-18
Effectiveness Date
2006-04-07

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT a19328def14a.htm DEF 14A 447610
2 GRAPHIC a19328a1932804.gif GRAPHIC 5394
3 GRAPHIC a19328a1932805.gif GRAPHIC 912
4 GRAPHIC a19328a1932801.gif GRAPHIC 9084
  Complete submission text file 0000936392-06-000324.txt   470705
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24274 | Film No.: 06749021
SIC: 2836 Biological Products, (No Diagnostic Substances)